The Bio Report
Levine Media Group
The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.
Get every episode summarized
Each time The Bio Report publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Episodes (1239)
Bringing Cellular Diversity into Sharper Focus
The Bio Report
Developing Cancer Therapies for When Damage Control Goes Awry
The Bio Report
Delivering the Goods
The Bio Report
Swimming in the New Oil
The Bio Report
Does This Drug Represent “A Paradigm Shift for Small Molecule Drug Development?”
The Bio Report
Exploring the Promise and Peril of CRISPR
The Bio Report
Transforming Protein Engineering with Generative AI
The Bio Report
Delivering Peptide Therapies Orally
The Bio Report
Creating A Drug Delivery ARMMs Race
The Bio Report
A Seek and Destroy Approach to Disease-Causing Proteins
The Bio Report
Teaching Tolerance to Address Autoimmune Diseases
The Bio Report
A Bet That the Next Blockbuster May Already Be Inside You
The Bio Report
A Big Mac Attack to Fight Cancer
The Bio Report
Getting Animated about Bioliteracy
The Bio Report
Reshaping Clinical Trial Designs with Real-World Data
The Bio Report
Using Generative AI to Produce Precise Gene Editors
The Bio Report
Enabling the Nervous System to Repair Itself
The Bio Report
Overcoming Barriers to Delivering Large Molecules to the Brain
The Bio Report
Developing Complex Therapies to Tackle Complex Diseases
The Bio Report
How Solving a Problem with Genetic Medicines May Solve Another with Infectious D...
The Bio Report
Boosting the Power of Dendritic Cancer Vaccines
The Bio Report
Overcoming Resistance in Cancer with Chemistry
The Bio Report
Teaching an Old Drug a New Trick to Prevent Lyme Disease
The Bio Report
A New Class of Cell Therapies to Target Solid Tumors
The Bio Report
Targeting the Tumor Microenvironment with Lipid-Based Immunotherapies
The Bio Report
A Company Born from a Father Who Wore His Heart on His Sleeve
The Bio Report
Using AI to Improve Burn Care
The Bio Report
A Home for Biotech in the City that Never Sleeps
The Bio Report
Biopharma R&D Growing Stronger
The Bio Report
The Benefits of Having a Multitude of Cins
The Bio Report
Making ADCs Smarter and Safer with a Simple Twist of Fate
The Bio Report
Targeting a Natural Repair System to Restore Brain Health
The Bio Report
Programing Cells in a Predictable and Scalable Way
The Bio Report
Why DNA May Be the Data Storage Medium of the Future
The Bio Report
Scouring Genetic Variation within Our Cells for Drug Targets
The Bio Report
Correcting Gene Dysregulation to Treat Diseases
The Bio Report
Using Technology to Regain Abilities after Spinal Cord Injury
The Bio Report
Why Drug Developers Have a Growing Interest in Targeting Mitochondria
The Bio Report
Beefing Up Computational Muscle to Understand Molecular Activity of Drug Candida...
The Bio Report
Targeting a Multitude of CIN in Cancer Cells
The Bio Report
The Year in Biotech and What’s Ahead in 2024
The Bio Report
Transforming Healthcare with Data
The Bio Report
Realizing the Promise of IL-2 Therapies with AI
The Bio Report
Unlocking Real-World Data to Improve Outcomes
The Bio Report
A Silicon Valley Entrepreneur Investing at the Intersection of Tech and Biotech
The Bio Report
A Company Betting Its Physics-Based AI Will Fuel a Quantum Leap in Drug Discover...
The Bio Report
Detecting Alzheimer’s Disease Early through a Blood Test
The Bio Report
Addressing Supply-Chain Challenges Underlying Drug Shortages with Synthetic Biol...
The Bio Report
Building Better and More Affordable Vaccines
The Bio Report
Overcoming Resistance to Targeted Therapies
The Bio Report